Zhang Y, Wilt E, Lu X. Human Isogenic Cell Line Models for Neutrophils and Myeloid-Derived Suppressor Cells. Int J Mol Sci. 2020;21: pubmed publisher

Ping Y, Li F, Nan S, Zhang D, Shi X, Shan J, et al. Augmenting the Effectiveness of CAR-T Cells by Enhanced Self-Delivery of PD-1-Neutralizing scFv. Front Cell Dev Biol. 2020;8:803 pubmed publisher

Xu X, Hou B, Fulzele A, Masubuchi T, Zhao Y, Wu Z, et al. PD-1 and BTLA regulate T cell signaling differentially and only partially through SHP1 and SHP2. J Cell Biol. 2020;219: pubmed publisher

Trinklein N, Pham D, Schellenberger U, Buelow B, Boudreau A, Choudhry P, et al. Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodies. MAbs. 2019;11:639-652 pubmed publisher

Bröker K, Terzenbach R, Bentzien F, Lüth S, Dammermann W. Complement factors C3a and C5a mimick a proinflammatory microenvironment and increase HBV IGRA sensitivity. J Transl Med. 2019;17:6 pubmed publisher

Tello Lafoz M, Rodriguez Rodriguez C, Kinna G, Loo L, Hong W, Collins B, et al. SNX27 links DGKζ to the control of transcriptional and metabolic programs in T lymphocytes. Sci Rep. 2017;7:16361 pubmed publisher

Dammermann W, Dornbrack J, Bröker K, Bentzien F, Lüth S. CpG oligonucleotides increase HBV-specific cytokine responses in whole blood and enhance cytokine release assay sensitivity. J Virol Methods. 2017;248:195-201 pubmed publisher

Karampetsou M, Comte D, Kis Toth K, Terhorst C, Kyttaris V, Tsokos G. Decreased SAP Expression in T Cells from Patients with Systemic Lupus Erythematosus Contributes to Early Signaling Abnormalities and Reduced IL-2 Production. J Immunol. 2016;196:4915-24 pubmed publisher

Sturner K, Borgmeyer U, Schulze C, Pless O, Martin R. A multiple sclerosis-associated variant of CBLB links genetic risk with type I IFN function. J Immunol. 2014;193:4439-47 pubmed publisher

Albring A, Wendt L, Harz N, Engler H, Wilde B, Witzke O, et al. Short-term treatment with the calcineurin inhibitor cyclosporine A decreases HPA axis activity and plasma noradrenaline levels in healthy male volunteers. Pharmacol Biochem Behav. 2014;126:73-6 pubmed publisher

Redkiewicz P, Wiesyk A, Gora Sochacka A, Sirko A. Transgenic tobacco plants as production platform for biologically active human interleukin 2 and its fusion with proteinase inhibitors. Plant Biotechnol J. 2012;10:806-14 pubmed publisher